Accurate adenovirus (Ad) quantification requires labor-and time-intensive viral stock purification. While crude viral lysates can be titered by plaque assay, this cell-based assay is neither rapid nor accurate. Consequently, a method for quantification of crude, unpurified viral culture lysates is needed. Given growing interest in alternative Ad serotypes (different from well-studied and characterized serotype Ad5) for basic research and for therapeutic applications, such a method should also apply to alternative serotypes. Using a Q Sepharose XL (QSXL) columnbased method, we describe a robust quantification method resulting in efficient retention of viral particles of all serotypes, while non-viral components of crude infected cultures remain largely in the flow-through. The highperformance liquid chromatography-QSXL method allows rapid, accurate adenoviral quantification in crude lysates as well as identification of the various serotypes present in mixed-serotype crude lysates. We also report on conditions that efficiently strip and regenerate the column, extending its functional life. Gene Therapy (2007) Efficient and effective development of oncolytic viruses and virotherapies requires rapid assessment of the relative potencies of a large variety of viral candidates. As these viruses may differ in cellular tropisms, these potencies must be assessed on a per viral particle basis. Additionally, development of these agents may require rapid identification of the variety of viruses present in any given mixed-serotype lysate without viral purification before quantification. This report describes a comprehensive method that simultaneously accomplishes these objectives.
Efficient and effective development of oncolytic viruses and virotherapies requires rapid assessment of the relative potencies of a large variety of viral candidates. As these viruses may differ in cellular tropisms, these potencies must be assessed on a per viral particle basis. Additionally, development of these agents may require rapid identification of the variety of viruses present in any given mixed-serotype lysate without viral purification before quantification. This report describes a comprehensive method that simultaneously accomplishes these objectives.
Methods have been explored to improve the speed and accuracy of adenoviral particle quantification, many of them based on chromatographic approaches. For example, Shabram et al. 1 described a method for quantification of purified adenoviral particles based on Resource Q anion-exchange resin. The Shabram method was improved by use of an alternate anion-exchange resin, Fractogel EMD TMAE-650(S) (TMAE), which allowed resolution of RNA and viral peaks (E Lehmberg, personal communication). This enhanced resolution was especially important for adenovirus (Ad)5 analyses as this viral serotype is strongly retained on anion exchange, and was formerly difficult to resolve from RNA and transfer RNA. However, despite the ability to resolve RNA from viral particles, TMAE is not ideal.
When running viruses in a series, the peak area of CsClpurified viral standards analyzed at the end of, or late in, a sequence of viral samples was often reduced more than 50% relative to the same standard analyzed at the start of the sequence. Peak areas for viral standards returned to their maxima when column compaction was reversed by allowing the column to rest for at least 24 h, by backflow, or by repacking the column. The tendency of the relatively soft TMAE matrix to compact, compromising viral particle recovery, increased for adenoviral particles in crude culture lysates. In spite of sample centrifugation and filtration, crude lysate samples clogged the column, increasing column backpressure and promoting TMAE bead compression and/or column compaction. The peak areas of purified viral standards analyzed between crude viral culture lysate samples showed that the TMAE column was rapidly compromised, requiring extensive stripping and salt regeneration combined with backflow or column repacking before the peak area of the viral quantification standard was restored. It is worth noting that when samples of pure BSA (bovine serum albumin) standards were run on compressed TMAE columns (i.e. those that appeared to exclude viral particles), the protein peak areas were not affected. We hypothesize that when the TMAE beads are compressed, the viral particles, due to their large size, cannot access sufficient anion-exchange sites to be retained on the resin and so appear in the column flow-through (data not shown) rather than eluting at their known retention time. On the other hand, we theorize that BSA protein standard and multimers are sufficiently small to access sites, and their retention times remain unaffected by column compression adversely affecting viral peak areas. These experiences with TMAE led us to test the use of an alternate, more rigid column matrix.
One such method, reported by Blanche et al., 2 allowed reproducible quantification of virus of several serotypes in crude lysates by employing Q Sepharose XL (QSXL). We tested the QSXL-based method for the analysis of crude viral lysate samples, but found that contaminants eluting at the beginning of the salt gradient obscured adenoviral serotypes, such as Ad3, Ad9 and Ad16, that elute in a similar region of the gradient. To improve sensitivity and precision, we sought to eliminate contaminating peaks from the chromatogram. We tested alternative starting buffer conditions in which the salt concentration was increased in 20 mM increments from 0.01 M NaCl to 0.1 M NaCl (data not shown). The majority of non-viral culture components that bound under the no-salt buffer conditions (and co-eluting early in the salt gradient with early-eluting viral serotypes) were not retained when 0.1 M NaCl salt was added to the starting buffer. Use of 0.1 M NaCl, 20 mM Tris (pH 7.5) starting buffer is critical to ensuring non-viral culture lysate components elute in the column flow-through, while allowing quantifiable virus peaks to elute at known retention times.
Although increasing the ionic strength of the initial mobile phase increased the number of non-viral components in the column flow-through, we needed to rule out the possibility that it interfered with efficient binding of the less anionic serotypes. The mechanism of adenoviral interaction with QSXL has not been fully characterized; it is generally assumed that the acidic L1 loop of hexon of each serotype is the dominant factor controlling binding. 2 The sequence of hexon, and of the L1 loop of hexon, varies with adenoviral serotype. Therefore, we performed individual testing of each serotype to determine the salt conditions that permit efficient binding to QSXL. For instance, Ad5 virions bind QSXL efficiently at 0.3 M NaCl, while Ad3 virions do not. Our goal was to develop a method that would allow as many non-viral components as possible to pass through the column (in the flow-through) while efficiently retaining viral particles of all serotypes.
We performed high-performance liquid chromatography (HPLC)-QSXL analyses on a variety of serotypes representing different Ad subgroups (Figure 1 ). Spectro- Figure 1 QSXL chromatograms of pure Ad stocks. HPLC separations were performed using an Agilent 1100 HPLC that included a well-plate autosampler, quaternary pump and multiwavelength detector. An in-line conductivity meter was used to follow actual salt conditions. Samples and buffers were at ambient temperature, and the column compartment was controlled at 221C. Pharmacia HR 5/5 columns were packed with 1.25 ml bed volume of QSXL (GE Healthcare, no. 17-5072-01) anion-exchange media. The mobile phases were Buffer A, 20 mM Tris/HCl, pH 7.5, 0.1 M NaCl, and Buffer B, 20 mM Tris/HCl, pH 7.5, 1 M NaCl. The flow rate was 1 ml/min, except during the strip method at which time flow rate decreased to 0.02 ml/min. Typical sample injection volume was 0.1 ml; up to 1 ml sample volume of very low titer viral stocks was loaded. A 0.5 mm prefilter was included upstream of the column to extend the life of the column, and this prefilter was changed after no more than 15 crude samples were injected onto the column. The column was equilibrated for 4 column volumes (CV) with Buffer A. After sample loading, the column was washed with 4 CV of Buffer A, followed by sample separation with a linear salt gradient of 0-55% Buffer B over 15 CV, 2 CV of 70% Buffer B, then a second gradient of 70-100% Buffer B over 2 CV, which constituted the first salt regeneration of the column. The column was then reequilibrated with 5 CV of Buffer A before stripping. The column was stripped (cleaned of any remaining nucleic acids) by loading 1 CV of 0.5 N NaOH, reducing the pump flow rate to 0.02 ml/min for 10 min, followed by 3 CV of Buffer A at 1 ml/min flow rate. This strip step was followed by a salt regeneration step of 3 CV of 100% Buffer B. The column was then re-equilibrated by 10 CV of Buffer A before loading the next sample. Prior to using QSXL, columns for viral particle separations were packed with Fractogel EMD TMAE-650(S) (EM Science, Gibbstown, NJ, USA) (TMAE), and the buffers and gradients used were those specified by Shabram et al. 1 All adenovirus serotypes (Ad3, Ad5, Ad9, Ad11p, Ad16, Ad35) were obtained from the ATCC (American Type Culture Collections). Viral stocks for HPLC viral titer analysis were prepared by infection of A549, 293, HT-29 or PC-3 cells. All cells were obtained from the ATCC, and were grown to approximately 70-80% confluency in the ATCC-recommended culture media before infection. Cells were infected at multiplicity of infection (MOI) of 1-10 in Dulbecco's modified Eagle's media Gibco (Invitrogen, Frederick, MD) supplemented with 2% FBS (Hyclone, Logan, Utah), 2 mM glutamine and gentimicin. Full cytopathic effect (CPE) was generally reached by 48-72 h post-infection, at which time the viral lysates were harvested. Cells and supernatants were harvested, cells ruptured by 1-3 cycles of freeze-thaw, cell debris pelleted by a 5 min centrifugation at 3000 r.p.m. in a Beckman Allegra 6R centrifuge and the viral stock supernatants collected. These crude viral lysates were filtered through 0.45 mm filters before loading on the QSXL columns. For preparation of pure viral stocks, virus was purified from the crude lysates using the cesium chloride buoyant density method as described by Tollefson et al. 3 Viral HPLC peaks are identified after QSXL chromatography due to their distinctively narrow shape, their 260 nm/280 nm ratio of 1.3370.06 and the distinctive serotype retention times. The Ad5 chromatogram is that of our viral standard for quantification, an Ad5 stock that was purified, then analyzed by reversed-phase HPLC to determine the exact number of viral particles per ml. 4 The titers of test viral stocks are derived by comparison to the peak area of this standard. 1 The chromatograms are of pure stocks of each of the adenovirus serotypes used in this study. The retention times of the serotypes are given in the figure.
HPLC method for rapid assessment of viral particle number I Kuhn et al photometrically titered pure stocks of each serotype were analyzed, and the viral peaks quantified relative to a viral standard included in every HPLC sequence. Viral titers are directly proportional to the area under the curve of the A 260 nm chromatographic viral peak within the range used here.
1,2 Integration of peak areas was carried out throughout using Agilent ChemStations Software version B.01.03, including Agilent's standard integrator algorithm. The titer of the pure viral standard for viral particle quantification was determined by reversed-phase HPLC according to Lehmberg et al. 4 Titers of test viral stocks could therefore be derived from the ratio of the A 260 nm test viral peak area to that of the standard. HPLC titers agreed within 5% with the spectrophotometric titers for each stock. We observed efficient retention of all viral serotypes in 0.1 M NaCl-Tris starting buffer, and efficient elution at each serotypes' anionic equivalence point in the separation gradient. The retention time of each serotype is noted in Figure 1 . Flow rates were 1 ml/min throughout all separation gradients.
We next generated chromatograms of crude viral stocks (lysates) of each of the serotypes of interest using the 0.1 M NaCl-Tris starting buffer (Buffer A mobile phase). Typical chromatograms are presented in Figure 2 . Like purified viral stocks, the viral peaks in chromatograms of crude viral lysates are characteristically narrow, have 260/280 nm ratios of B1.3 and retention times characteristic of the pure serotype samples presented in Figure 1 . The crude viral lysates contain non-viral proteins and other contaminants. Serum proteins were identified in the chromatograms of crude viral lysates as broad, unresolved (usually bimodal) peaks extending from 8 to 16 min in the chromatogram, having 260/ 280 nm ratios and retention times characteristic of pure serum protein standards analyzed on the same column (data not shown). Similarly, chromatographic peaks representing nucleic acids were identified by 260/ Figure 3 Pooled Ad serotypes can be accurately quantified by QSXL-HPLC analysis, whether pure or spiked into a crude viral lysate. Several pure adenoviral stocks (Ad3, Ad9, Ad11p) were combined, and each component serotype quantified by QSXL-HPLC. The viral titer results matched stock titers obtained by spectrophotometry and by HPLC analysis of the individual purified viral stocks. The combined pure stocks were then spiked into a crude viral lysate of an Ad5-infected culture. As reflected in the integrated peak areas noted in the figure and also in the associated table, the peak areas of the spiked pure stocks matched within 10% their respective peak areas obtained in the absence of a crude viral lysate. Similarly, various combinations of pure viral stocks were spiked into crude viral lysates of each serotype prepared on a variety of cell types. In each case, the peak areas of the viruses spiked into the crude stocks matched the peak area of the virus analyzed in pure form.
HPLC method for rapid assessment of viral particle number I Kuhn et al 280 nm ratios of B1.8 and the long retention times characteristic of pure nucleic acid standards (data not shown). These studies indicate that the buffer modifications to the Blanche protocol are useful for quantification of viral particles in both purified and crude viral lysate stocks.
Quantitative recovery of virus spiked into crude viral lysates
To qualify our HPLC-QSXL method for quantification of viral particles in crude viral lysates, we spiked known numbers of purified viral particles into crude lysates, and demonstrated full recovery (Figure 3 ). The serotype of the pure stocks used for spiking was chosen so that the viral peaks of the spiked virus, and the viral peak of the virus endogenous to that particular crude viral lysate could be easily distinguished. These spiking tests were first carried out using individual serotype stocks, and then using combinations of various serotypes, as presented in Figure 3 . In all cases, the integrated peak areas of the pure viral stocks were identical to the integrated peak areas of the same viruses spiked into crude viral lysate.
To investigate the sensitivity of the method, serial dilutions of spectrophotometrically titered viral stocks were spiked into crude lysates. Quantification of the resultant viral peaks demonstrated the sensitivity of the method to be 1 mAU per 1 Â 10 7 viral particles. This level of sensitivity is about 10-fold higher than reported previously.
2 Accurate quantification consequently requires about 1 Â 10 8 viral particles in the injected sample; routine sample size is 100 ml. Larger-volume samples can be injected, but the level of contaminants may obscure viral peaks. The sensitivity of the method can therefore be problematic for crude viral lysates with titers below 1-5 Â 10 9 viral particles per ml.
Congruence between physical and functional titration of viral stocks
We chose the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) (CellTiter 96 nonradioactive cell proliferation assay; Promega; Madison, WI, USA) assay to evaluate the accuracy of viral particle quantification in crude viral lysates. Each virus has a distinct 'per viral particle' potency on a given cell type when assessed by MTS assay. Thus, MTS assay potency is sensitive to the accuracy of viral particle quantification. We therefore qualified the method by demonstrating equivalent potency of pure and crude viral stocks quantified by QSXL-HPLC, as detailed below. We prepared crude viral lysates and purified stocks of six viruses, for a total of 12 stocks. The titer of each purified stock was determined by spectrophotometer 5, 6 and by the HPLC-QSXL method reported here; the titers of each stock by these two methods agreed within 10% of one another. The titers of the crude viral lysates were assessed by HPLC-QSXL method. Based on these viral titers, PC-3 cells were infected with each stock starting at a viral-particle-to-cell ratio of 100:1 and continuing across the 96-well plates in threefold serial dilution. Each assay was carried out in quadruplicate. Mitochondrial function was measured at 7 days post-infection using MTS assay. The results, presented in Figure 4 , indicate that the potency of each of the six viruses was unaffected Figure 4 MTS assay (CellTiter 96 non-radioactive cell proliferation assay; Promega; Madison, WI, USA) of matched pure and crude viral stocks' potency on PC-3 cells. PC-3 cells used in the MTS assay were grown in F-12K media as recommended by American Type Culture Collection. Twelve viral stocks, a purified stock and a crude stock of each, were prepared for six viruses. The 12 stocks were quantified by QSXL-HPLC. The spectrophotometric titers of the pure stocks were within 10% of their QSXL-HPLC titers. MTS assays (which measure mitochondrial function attenuated by viral infection) were performed based on the HPLC titers for all 12 stocks (six pure, six crude). For the assay, cells were seeded into 96-well plates at a density such that confluency was reached by 48 h postseeding, cultures were incubated for an additional 24 h after reaching confluency and cells were infected at 72 h post-seeding. Cells were infected with 100 viral particles per cell, using viral particle concentrations determined by the QSXL-HPLC method described in this report and consecutive columns of the 96-well plates were infected following threefold serial dilution of the viral stock. The Promega colorimetric reagent was added to the wells of the plate several days after infection (time dependent on the cell type infected), and the results read following the manufacturer's directions (Promega). As indicated, the potencies of the pure and crude stock versions of each virus on PC-3 cells were closely comparable.
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In summary, by increasing the ionic strength of the initial mobile phase, we were able to greatly reduce interference from non-viral crude stock components by directing them to the column flow-through, without viral loss. Sensitivity of the method, especially for earlyeluting serotypes, increased over 10-fold as a result: we could get accurate viral titers from 50 to 100 ml of crude lysate, whereas the Blanche method requires analysis of milliliter quantities of similar samples for accuracy. 2 Improvements to the column stripping and regeneration steps of the method further increased sensitivity and accuracy. Increasing column-residence time of the NaOH strip solution by decreasing flow rates during the strip, followed by a second salt regeneration step, greatly improved column cleaning, extending column life.
We demonstrated the accuracy of our QSXL method for quantification of purified viral stocks by comparison of viral titers obtained by spectrophotometric, reversedphase HPLC and our HPLC-QSXL methods. We extrapolated the accuracy of our QSXL method for quantification of viral particles in crude culture lysates based on sensitive and accurate quantification of pure viral stocks spiked into crude lysates. We then showed equivalent potency of matched crude and pure viral stocks, both quantified by HPLC-QSXL, in a series of MTS assays. Comparison of potencies in an MTS assay demonstrated the accuracy of our viral quantification method for both crude and purified viral stocks.
Use of this method allows accurate quantification of multiple viral particle types in a single crude culture lysate. The method is accurate for the wide variety of adenoviral serotypes tested, allowing subsequent determination of the potencies of the viruses in crude viral lysates by functional assays such as the MTS assay used here. Through the use of an in-line fraction collector, the method allows isolation of any virus(es) in a crude culture mixed-viral-type stock. The potency of such isolated viruses can be re-assessed to identify those of particular interest. In this manner, we can move rapidly from pools of candidate viruses to identification and isolation of single viruses meeting selected criteria for further development as therapeutic agents.
Occasionally, we work with crude lysates whose low titer and retention time complicate quantification. To try to extend the sensitivity of the method, we explored using reference chromatogram subtraction. An example is presented in inset A and B of Figure 2 . In the example used here, quantification of Ad3 is complicated because Ad3 virions co-elute with fetal bovine serum (FBS) protein present in the culture media. Since we observe that chromatograms of conditioned FBS from infected cultures differ from those of unconditioned FBS, unconditioned FBS chromatogram subtraction is not necessarily accurate. Therefore, to facilitate accurate quantification of, for example, Ad3 crude lysates, a crude lysate of Ad11p was prepared and analyzed in parallel as presented in Figure 2 (inset A and B) . By subtracting the chromatogram of the Ad11p lysate from that of Ad3, inaccuracies due to co-eluting media components could be minimized, and the sensitivity of the method increased. This subtraction method was qualified for various serotype combinations using dilutions of known titer samples spiked into crude lysates, and then subtracting the chromatogram of an alternate serotype. Viral peak integration after chromatogram subtraction yielded accurate titer information. We have not performed this qualification for all combinations of serotypes, but we have no reason to expect that it would not be accurate.
By eliminating the need to purify viral stocks before quantifying, the described QSXL method greatly increases the speed of analysis, and reduces the hands-on time and cost of assessing and selecting viral agents for further development. This method thus improves the speed and accuracy of adenoviral quantification as well as characterizing the mixture of serotypes present in any given crude viral lysate.
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